- Mots-clés > access to antiretroviral treatment
- Mots-clés > active surveillance system - antiretroviral program
- Mots-clés > adverse drug reactions (ADRs)
- Mots-clés > adverse event (AE)
- Mots-clés > antiretroviral medicines
- Mots-clés > antiretroviral therapy (ART)
- Mots-clés > efficacy and safety of medicines
- Mots-clés > HIV/AIDS-related drugs
- Mots-clés > national reporting systems - adverse reactions to medicines
- Mots-clés > pharmacovigilance
(2014; 110 pages)
Dlamini, Vusi C., et al. 2014. Antiretroviral Cohort Adverse Event Monitoring In Kwazulu-Natal. Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health.
The ACADEMIK cohort study was undertaken with the ultimate aim of establishing and sustaining an active cohort event monitoring surveillance for ARVs within the public health sector in KZN. The main purpose was for the province to be able to collect information on ARV AEs in a more structured and scientifically validated way that would allow for dissemination and use of the information for decision-making purposes. This would have contributed to the existing knowledge on ARVs thereby enhancing quality of care of patients on the ARV programme.
Despite the challenges faced with the ACADEMIK study, there are undoubted benefits to implementing active surveillance of AEs within the ARV treatment programme. It should therefore continue to be given importance. The ACADEMIK study can serve as a catalyst for sustainable active surveillance at specific sites. With adequate capacity, hospitals that showed potential for yielding good data may continue to be supported and strengthened in the follow-up of their patients through the use of the IePRS system.